Effect of Natural Antioxidant Supplement on Sperm DNA Fragmentation
NCT ID: NCT03646825
Last Updated: 2023-02-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
54 participants
OBSERVATIONAL
2018-08-01
2022-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Antioxidant Treatment on DNA Fragmentation Index
NCT03466229
Level of DNA-fragmentation Before and After Antioxidant-based Therapies in Male Infertility
NCT06050031
Oxidative Stress In Semen And Male Infertility
NCT03464656
DNA Fragmentation - Effect on Pregnancy Rate
NCT05397314
Effect of Dietary DHA Supplementation on Sperm Quality
NCT01368484
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment group
Male patients exposed to antioxidant for 12 weeks
Natural Antioxidant supplement
1 capsule orally three times a day for 12 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Natural Antioxidant supplement
1 capsule orally three times a day for 12 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
55 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Colorado Center for Reproductive Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rachel Makloski
Role: STUDY_CHAIR
Study Coordinator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Colorado Center for Reproductive Medicine
Lone Tree, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20170532
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.